表紙:更年期障害治療薬の世界市場:ステージタイプ、治療タイプ、製品タイプ、投与経路タイプ、エンドユーザー、地域別の市場規模調査と予測(2022~2028年)
市場調査レポート
商品コード
1070305

更年期障害治療薬の世界市場:ステージタイプ、治療タイプ、製品タイプ、投与経路タイプ、エンドユーザー、地域別の市場規模調査と予測(2022~2028年)

Global Menopause Drug Market Size study, by Stages Type by Treatment Type by Product Type by Route of Administration Types by End-Users and Regional Forecasts 2022-2028

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
更年期障害治療薬の世界市場:ステージタイプ、治療タイプ、製品タイプ、投与経路タイプ、エンドユーザー、地域別の市場規模調査と予測(2022~2028年)
出版日: 2022年03月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の更年期障害治療薬市場は、2022~2028年の予測期間中に健全な成長率で成長すると予測されています。

40-65歳の女性の割合が増加していることが、予測期間中の更年期障害治療薬の採用につながりました。また薬剤の研究開発の増加に伴い、採用と需要が増加し、予測期間中の市場成長を高めると予想されます。しかし、この薬に関する認知度の低さが、市場成長の阻害要因となっています。

当レポートでは、世界の更年期障害治療薬市場について調査分析し、業界分析、COVID-19の影響、ステージタイプ・治療タイプ・製品タイプ・投与経路タイプ・エンドユーザー・地域別市場分析、競合情勢に関する情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の更年期障害治療薬市場の定義と範囲

第3章 世界の更年期障害治療薬の市場力学

  • 更年期障害治療薬市場の影響分析(2020~2028年)

第4章 世界の更年期障害治療薬市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要ウィニング戦略

第5章 リスク評価:COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の更年期障害治療薬市場:ステージタイプ別

  • 市場スナップショット
  • 世界の更年期障害治療薬市場の潜在的な分析:ステージタイプ・パフォーマンス別
  • 世界の更年期障害治療薬市場の推定と予測:ステージタイプ別(2019~2028年(10億米ドル))
  • 更年期障害治療薬市場:サブセグメント分析
    • 閉経期
    • 更年期障害
    • 更年期障害後

第7章 世界の更年期障害治療薬市場:治療タイプ別

  • 市場スナップショット
  • 世界の更年期障害治療薬市場の潜在的な分析:治療タイプ・パフォーマンス別
  • 世界の更年期障害治療薬市場の推定と予測:治療タイプ別(2019~2028年(10億米ドル))
  • 更年期障害治療薬市場:サブセグメント分析
    • 非ホルモン療法
    • ホルモン療法
    • ハーブサプリメント

第8章 世界の更年期障害治療薬市場:製品タイプ別

  • 市場スナップショット
  • 世界の更年期障害治療薬市場の潜在的な分析:製品タイプ・パフォーマンス別
  • 世界の更年期障害治療薬市場の推定と予測:製品タイプ別(2019~2028年(10億米ドル))
  • 更年期障害治療薬市場:サブセグメント分析
    • パッチ
    • ピル
    • ジェル
    • 注射
    • クリーム
    • その他

第9章 世界の更年期障害治療薬市場:投与経路タイプ別

  • 市場スナップショット
  • 世界の更年期障害治療薬市場の潜在的な分析:投与経路タイプ・パフォーマンス別
  • 世界の更年期障害治療薬市場の推定と予測:投与経路タイプ別(2019~2028年(10億米ドル))
  • 更年期障害治療薬市場:サブセグメント分析
    • 経口
    • 注射可能
    • 外用剤

第10章 世界の更年期障害治療薬市場:エンドユーザー別

  • 市場スナップショット
  • 世界の更年期障害治療薬市場の潜在的な分析:エンドユーザー・パフォーマンス別
  • 世界の更年期障害治療薬市場の推定と予測:エンドユーザー別(2019~2028年(10億米ドル))
  • 更年期障害治療薬市場:サブセグメント分析
    • 病院
    • ホームケア
    • 専門クリニック
    • その他

第11章 世界の更年期障害治療薬市場:地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第12章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • Eli Lilly and Company
    • Cipla Inc
    • Allergan
    • Pfizer, Inc
    • Novo Nordisk A/S
    • Novartis AG
    • Merck & Co., Inc
    • Emcure
    • Viramal,
    • EuroPharma USA

第13章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Menopause Drug Market, report scope
  • TABLE 2. Global Menopause Drug Market estimates & forecasts by Region 2019-2028 (USD Billion)
  • TABLE 3. Global Menopause Drug Market estimates & forecasts by Stages Type 2019-2028 (USD Billion)
  • TABLE 4. Global Menopause Drug Market estimates & forecasts by Treatment Type 2019-2028 (USD Billion)
  • TABLE 5. Global Menopause Drug Market estimates & forecasts by Product Type 2019-2028 (USD Billion)
  • TABLE 6. Global Menopause Drug Market estimates & forecasts by Route of Administration Type 2019-2028 (USD Billion)
  • TABLE 7. Global Menopause Drug Market estimates & forecasts by End Users 2019-2028 (USD Billion)
  • TABLE 8. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 9. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 10. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 11. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 12. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 13. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 14. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 15. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 16. Global Menopause Drug Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 17. Global Menopause Drug Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 18. U.S. Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 19. U.S. Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 20. U.S. Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 21. Canada Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 22. Canada Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 23. Canada Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 24. UK Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 25. UK Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 26. UK Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 27. Germany Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 28. Germany Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 29. Germany Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 30. RoE Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 31. RoE Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 32. RoE Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 33. China Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 34. China Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 35. China Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 36. India Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 37. India Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 38. India Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 39. Japan Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 40. Japan Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 41. Japan Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 42. RoAPAC Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 43. RoAPAC Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 44. RoAPAC Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 45. Brazil Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 46. Brazil Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 47. Brazil Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 48. Mexico Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 49. Mexico Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 50. Mexico Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 51. RoLA Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 52. RoLA Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 53. RoLA Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 54. Row Menopause Drug Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 55. Row Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 56. Row Menopause Drug Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 57. List of secondary sources, used in the study of global Menopause Drug Market
  • TABLE 58. List of primary sources, used in the study of global Menopause Drug Market
  • TABLE 59. Years considered for the study
  • TABLE 60. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Menopause Drug Market, research methodology
  • FIG 2. Global Menopause Drug Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Menopause Drug Market, key trends 2021
  • FIG 5. Global Menopause Drug Market, growth prospects 2022-2028
  • FIG 6. Global Menopause Drug Market, porters 5 force model
  • FIG 7. Global Menopause Drug Market, pest analysis
  • FIG 8. Global Menopause Drug Market, value chain analysis
  • FIG 9. Global Menopause Drug Market by segment, 2019 & 2028 (USD Billion)
  • FIG 10. Global Menopause Drug Market by segment, 2019 & 2028 (USD Billion)
  • FIG 11. Global Menopause Drug Market by segment, 2019 & 2028 (USD Billion)
  • FIG 12. Global Menopause Drug Market by segment, 2019 & 2028 (USD Billion)
  • FIG 13. Global Menopause Drug Market by segment, 2019 & 2028 (USD Billion)
  • FIG 14. Global Menopause Drug Market, regional snapshot 2019 & 2028
  • FIG 15. North America Menopause Drug Market 2019 & 2028 (USD Billion)
  • FIG 16. Europe Menopause Drug Market 2019 & 2028 (USD Billion)
  • FIG 17. Asia pacific Menopause Drug Market 2019 & 2028 (USD Billion)
  • FIG 18. Latin America Menopause Drug Market 2019 & 2028 (USD Billion)
  • FIG 19. Global Menopause Drug Market, company Market share analysis (2021)
目次

Global Menopause Drug Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. (Mar) Menopause Drug is a type of walk-in clinic that provides ambulatory care in a dedicated medical facility outside of a conventional emergency room (ER). Also, the Menopause Drug is used for treating injuries and illness that need immediate care. The increase in percentage of women aged 40-65 years impacted them the most has led the adoption of Menopause Drug across the forecast period. According to a survey conducted in 2021 by Statista, 1 in 6 women aged 40 to 65 claimed hot flashes were the most bothersome symptom of menopause. Another 15% experienced weight increase, with vaginal dryness and uncomfortable sex affecting the majority of women (12%). As of 2021, this statistic shows the percentage of women aged 40 to 65 in the United States who reported that menopause symptoms affected them the most. Also, with the increasing research and development in the drugs, the adoption & demand for Menopause Drug is likely to increase the market growth during the forecast period. However, low awareness regarding this drug impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Menopause Drug Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to the high prevalence of unhealthy lifestyle and rising introduction of novel drugs in this region. Whereas, Asia-Pacific is anticipated to exhibit highest CAGR over the forecast period 2022-2028. Factors such as increase in the vulnerable aging population of menopause women and increase in the demand of novel therapies would create lucrative growth prospects for the Menopause Drug Market across Asia-Pacific region.

Major market player included in this report are:

Teva Pharmaceutical Industries Ltd.

Eli Lilly and Company

Cipla Inc

Allergan

Pfizer, Inc

Novo Nordisk A/S

Novartis AG

Merck & Co., Inc

Emcure

Viramal,

EuroPharma USA

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Stages Type:

Perimenopause

Menopause

Post menopause

By Treatment Type:

Non-Hormonal Treatment

Hormonal Treatment

Herbal Supplements

By Product Type:

Patch

Pill

Gel

Injectable

Cream

Others

By Route of Administration Type:

Oral

Injectable

Topical

By End Users:

Hospitals

Homecare

Specialty Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Menopause Drug Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Menopause Drug Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Menopause Drug Market, by Stages Type, 2020-2028 (USD Billion)
    • 1.2.3. Menopause Drug Market, by Treatment Type, 2020-2028 (USD Billion)
    • 1.2.4. Menopause Drug Market, by Product Type, 2020-2028 (USD Billion)
    • 1.2.5. Menopause Drug Market, by Route of Administration Type, 2020-2028 (USD Billion)
    • 1.2.6. Menopause Drug Market, by End Users, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Menopause Drug Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Menopause Drug Market Dynamics

  • 3.1. Menopause Drug Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing percentage of women aged 40-65 years who are suffering from menopause
    • 3.1.2. Market Challenges
      • 3.1.2.1. Low awareness regarding this drug
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing research and development in the drugs

Chapter 4. Global Menopause Drug Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Menopause Drug Market, by Stages Type

  • 6.1. Market Snapshot
  • 6.2. Global Menopause Drug Market by Stages Type, Performance - Potential Analysis
  • 6.3. Global Menopause Drug Market Estimates & Forecasts by Stages Type 2019-2028 (USD Billion)
  • 6.4. Menopause Drug Market, Sub Segment Analysis
    • 6.4.1. Perimenopause
    • 6.4.2. Menopause
    • 6.4.3. Post menopause

Chapter 7. Global Menopause Drug Market, by Treatment Type

  • 7.1. Market Snapshot
  • 7.2. Global Menopause Drug Market by Treatment Type, Performance - Potential Analysis
  • 7.3. Global Menopause Drug Market Estimates & Forecasts by Treatment Type 2019-2028 (USD Billion)
  • 7.4. Menopause Drug Market, Sub Segment Analysis
    • 7.4.1. Non-Hormonal Treatment
    • 7.4.2. Hormonal Treatment
    • 7.4.3. Herbal Supplements

Chapter 8. Global Menopause Drug Market, by Product Type

  • 8.1. Market Snapshot
  • 8.2. Global Menopause Drug Market by Product Type, Performance - Potential Analysis
  • 8.3. Global Menopause Drug Market Estimates & Forecasts by Product Type 2019-2028 (USD Billion)
  • 8.4. Menopause Drug Market, Sub Segment Analysis
    • 8.4.1. Patch
    • 8.4.2. Pill
    • 8.4.3. Gel
    • 8.4.4. Injectable
    • 8.4.5. Cream
    • 8.4.6. Others

Chapter 9. Global Menopause Drug Market, by Route of Administration Type

  • 9.1. Market Snapshot
  • 9.2. Global Menopause Drug Market by Route of Administration Type, Performance - Potential Analysis
  • 9.3. Global Menopause Drug Market Estimates & Forecasts by Route of Administration Type 2019-2028 (USD Billion)
  • 9.4. Menopause Drug Market, Sub Segment Analysis
    • 9.4.1. Oral
    • 9.4.2. Injectable
    • 9.4.3. Topical

Chapter 10. Global Menopause Drug Market, by End Users

  • 10.1. Market Snapshot
  • 10.2. Global Menopause Drug Market by End Users, Performance - Potential Analysis
  • 10.3. Global Menopause Drug Market Estimates & Forecasts by End Users 2019-2028 (USD Billion)
  • 10.4. Menopause Drug Market, Sub Segment Analysis
    • 10.4.1. Hospitals
    • 10.4.2. Homecare
    • 10.4.3. Specialty Clinics
    • 10.4.4. Others

Chapter 11. Global Menopause Drug Market, Regional Analysis

  • 11.1. Menopause Drug Market, Regional Market Snapshot
  • 11.2. North America Menopause Drug Market
    • 11.2.1. U.S. Menopause Drug Market
      • 11.2.1.1. Stages Type breakdown estimates & forecasts, 2019-2028
      • 11.2.1.2. Treatment Type breakdown estimates & forecasts, 2019-2028
      • 11.2.1.3. Product Type breakdown estimates & forecasts, 2019-2028
      • 11.2.1.4. Route of Administration Type breakdown estimates & forecasts, 2019-2028
      • 11.2.1.5. End Users breakdown estimates & forecasts, 2019-2028
    • 11.2.2. Canada Menopause Drug Market
  • 11.3. Europe Menopause Drug Market Snapshot
    • 11.3.1. U.K. Menopause Drug Market
    • 11.3.2. Germany Menopause Drug Market
    • 11.3.3. France Menopause Drug Market
    • 11.3.4. Spain Menopause Drug Market
    • 11.3.5. Italy Menopause Drug Market
    • 11.3.6. Rest of Europe Menopause Drug Market
  • 11.4. Asia-Pacific Menopause Drug Market Snapshot
    • 11.4.1. China Menopause Drug Market
    • 11.4.2. India Menopause Drug Market
    • 11.4.3. Japan Menopause Drug Market
    • 11.4.4. Australia Menopause Drug Market
    • 11.4.5. South Korea Menopause Drug Market
    • 11.4.6. Rest of Asia Pacific Menopause Drug Market
  • 11.5. Latin America Menopause Drug Market Snapshot
    • 11.5.1. Brazil Menopause Drug Market
    • 11.5.2. Mexico Menopause Drug Market
  • 11.6. Rest of The World Menopause Drug Market

Chapter 12. Competitive Intelligence

  • 12.1. Top Market Strategies
  • 12.2. Company Profiles
    • 12.2.1. Teva Pharmaceutical Industries Ltd.
      • 12.2.1.1. Key Information
      • 12.2.1.2. Overview
      • 12.2.1.3. Financial (Subject to Data Availability)
      • 12.2.1.4. Product Summary
      • 12.2.1.5. Recent Developments
    • 12.2.2. Teva Pharmaceutical Industries Ltd.
    • 12.2.3. Eli Lilly and Company
    • 12.2.4. Cipla Inc
    • 12.2.5. Allergan
    • 12.2.6. Pfizer, Inc
    • 12.2.7. Novo Nordisk A/S
    • 12.2.8. Novartis AG
    • 12.2.9. Merck & Co., Inc
    • 12.2.10. Emcure
    • 12.2.11. Viramal,
    • 12.2.12. EuroPharma USA

Chapter 13. Research Process

  • 13.1. Research Process
    • 13.1.1. Data Mining
    • 13.1.2. Analysis
    • 13.1.3. Market Estimation
    • 13.1.4. Validation
    • 13.1.5. Publishing
  • 13.2. Research Attributes
  • 13.3. Research Assumption